Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Nutraceutical Reports Fiscal 2011 Q3 Results

July 28, 2011

PARK CITY, Utah, July 28, 2011 /PRNewswire/ — Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2011 third quarter ended June 30, 2011. Net sales for the fiscal 2011 third quarter were $47.5 million compared to $44.5 million for the same quarter of fiscal 2010. For the third quarter of fiscal 2011, net income was $3.9 million, or $0.38 diluted earnings per share, compared to net income of $3.8 million, or $0.36 diluted earnings per share, for the same quarter of fiscal 2010.

Net sales for the nine months ended June 30, 2011 were $142.2 million compared to $137.2 million for the same period in fiscal 2010. For the nine months ended June 30, 2011, net income was $12.4 million, or $1.19 diluted earnings per share, compared to net income of $12.8 million, or $1.22 diluted earnings per share, for the same period of fiscal 2010.

Operating cash flow for the nine months ended June 30, 2011 was $21.3 million compared to $13.3 million for the same period of fiscal 2010. This operating cash flow was primarily used to invest $9.3 million in acquisitions of branded natural product businesses, $9.2 million in purchases of property and equipment, $1.9 million in repurchases of common stock and $1.0 million to repay net borrowings on the Company’s revolving credit facility.

Bill Gay, chairman and chief executive officer, commented, “We are pleased with our fiscal 2011 third quarter net sales and net income growth. Cash flow and EBITDA remained strong despite ongoing expenses associated with the integration of our recently-acquired businesses. Management continues to focus on controllable expenses in an effort to offset and balance increases associated with utilities, freight and labor. In this slow-growth environment, acquisitions that are synergistic to our business model remain critical to our long-term success.”

Mr. Gay continued, “The business uncertainties associated with the economy have continued to unfavorably impact the perspectives of many of our primary health food store retailers. Fortunately, long-term loyal consumers of our brands remain eager for the health benefits our products provide them. Management believes this dichotomy will continue as long as there are no additional economic shocks. We intend to aggressively promote and market our brands and look for additional ways to reduce or hold costs. Management remains optimistic about its ability to grow the company and appreciates all those stakeholders that support us in this effort.”

ABOUT NUTRACEUTICAL

We are an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold primarily to and through domestic health and natural food stores. Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. Our core business strategy is to acquire, integrate and operate businesses in the natural products industry that manufacture, market and distribute branded nutritional supplements. We believe that the consolidation and integration of these acquired businesses provides ongoing financial synergies through increased scale and market penetration, as well as strengthened customer relationships.

We manufacture and sell nutritional supplements and other natural products under numerous brands including Solaray®, KAL®, Nature’s Life®, LifeTime®, Natural Balance®, bioAllers®, Herbs for Kids(TM), NaturalCare®, Health from the Sun®, Life-flo®, Organix South®, Pioneer® and Monarch Nutraceuticals(TM).

We own neighborhood natural food markets, which operate under the trade names The Real Food Company(TM), Thom’s Natural Foods(TM) and Cornucopia Community Market(TM). We also own health food stores, which operate under the trade names Fresh Vitamins(TM) and Granola’s(TM).

We manufacture and/or distribute one of the broadest branded product lines in the industry with over 5,500 SKUs, including over 700 SKUs sold internationally. We believe that as a result of our emphasis on innovation, quality, loyalty, education and customer service, our brands are widely recognized in health and natural food stores and among their customers.

This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forward-looking statements can be identified by the use of terms such as “believe,” “expects,” “plan,” “intend,” “may,” “will,” “should,” “can,” or “anticipates,” or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the nutritional supplement industry or the healthy foods channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiencies and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control. Copies of our SEC reports are available upon request from our investor relations department or may be obtained at the SEC’s website (www.sec.gov).

© 2011 Nutraceutical Corporation. All rights reserved.

              NUTRACEUTICAL INTERNATIONAL CORPORATION
               CONDENSED CONSOLIDATED BALANCE SHEETS
                 (unaudited; dollars in thousands)
                                     June 30,       September 30,
                                     --------       -------------
                                         2011                2010
    Assets
         Current assets, net          $59,725             $58,294
         Property, plant and
          equipment, net               70,486              61,733
         Goodwill                       7,163               5,338
         Other non-current assets,
          net                          30,619              30,966
                                       ------              ------
                                     $167,993            $156,331
                                     --------            --------

    Liabilities and
     Stockholders' Equity
         Current liabilities          $19,049             $45,673
         Long-term liabilities         28,330               1,739
         Stockholders' equity         120,614             108,919
                                     $167,993            $156,331
                                     --------            --------

                         NUTRACEUTICAL INTERNATIONAL CORPORATION
                     CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                (unaudited; dollars in thousands, except per share data)
                             Three months ended June   Nine months ended June
                                        30,                      30,
                             ------------------------ -----------------------
                                   2011          2010       2011         2010
    Net sales                   $47,453       $44,506   $142,245     $137,241
    Cost of sales                23,546        21,523     69,462       65,441
                                 ------        ------     ------       ------
        Gross profit             23,907        22,983     72,783       71,800
    Operating expenses
        Selling, general and
         administrative          17,076        16,381     51,323       49,809
        Amortization of
         intangible assets          419           329      1,213          941
                                    ---           ---      -----          ---
    Income from operations        6,412         6,273     20,247       21,050
    Interest and other
     (income) expense, net          293           147        802          403
                                    ---           ---        ---          ---
    Income before
     provision for income
     taxes                        6,119         6,126     19,445       20,647
    Provision for income
     taxes                        2,174         2,332      7,001        7,808
                                  -----         -----      -----        -----

    Net income                   $3,945        $3,794    $12,444      $12,839
                                 ------        ------    -------      -------

    Net income per common
     share
        Basic                     $0.38         $0.37      $1.20        $1.23
        Diluted                    0.38          0.36       1.19         1.22

    Weighted average
     common shares
     outstanding
        Basic                10,302,791    10,386,829 10,350,808   10,420,505
        Diluted              10,365,783    10,493,005 10,417,839   10,514,073

                                 NUTRACEUTICAL INTERNATIONAL CORPORATION
                                             EBITDA SCHEDULE
                                    (unaudited; dollars in thousands)
                             Three months ended        Nine months ended June
                                  June 30,                      30,
                             ------------------  -----------------------
                             2011           2010       2011            2010

    Net income             $3,945         $3,794    $12,444         $12,839
    Provision for income
     taxes                  2,174          2,332      7,001           7,808
    Interest and other
     (income) expense, net
     (1)                      293            147        802             403
    Depreciation and
     amortization           2,023          1,913      5,998           5,440
                            -----          -----      -----           -----

    EBITDA                 $8,435         $8,186    $26,245         $26,490
                           ------         ------    -------         -------
    (1)  Includes amortization of deferred financing fees.

    Non-GAAP Financial Measures
         EBITDA (a non-GAAP measure) is defined in our debt covenants and
          performance measures as earnings before net interest and other
          (income) expense, taxes, depreciation and amortization.  We believe
          that EBITDA provides useful additional information to analysts,
          creditors, investment bankers and management regarding operating
          performance and debt covenant compliance.  EBITDA has some inherent
          limitations in measuring operating performance due to the exclusion
          of certain financial elements such as depreciation and amortization
          and is not necessarily comparable to other similarly-titled
          captions of other companies due to potential inconsistencies in the
          method of calculation.  Furthermore, EBITDA is not intended to be
          an alternative to net income in determining our operating
          performance in accordance with generally accepted accounting
          principles.

SOURCE Nutraceutical International Corporation


Source: newswire